Jasper Therapeutics- Units (1 Ord Class A & 1/2 War) Accounts Payable

As of the most recent data (June 2026), AMHCU shows a accounts payable of $2.8M. That compares with $8M in the prior-year period — down 65.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AMHCU's accounts payable is now $2.8M (was $8M) — a 65.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Jasper Therapeutics- Units (1 Ord Class A & 1/2 War) is outperforming or lagging.

Tracking AMHCU's accounts payable over time shows whether Jasper Therapeutics- Units (1 Ord Class A & 1/2 War) is scaling, shrinking, or reshaping that part of the business. The current reading is $2.8M That compares with $8M in the prior-year period — down 65.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Jasper Therapeutics- Units (1 Ord Class A & 1/2 War)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $2.8M) with ownership activity and broader fundamentals.